Search research articles
Contact Us
Filters
Showing results (401-410 of 507) with videos related to
Page
of 51
Sort By:
The Biochemical Journal
|
January 1, 1993
Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains
F Desarnaud, J Marie, C Lombard, et al.
The American Journal of Pathology
|
February 18, 2014
Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis
Carole Le Henaff, Eric Haÿ, Frédéric Velard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 4, 2017
Anti-tumour necrosis factor α-induced lupus erythematosus panniculitis
A-L Durand, J-F Goussot, D Thiolat, et al.
The Journal of Biological Chemistry
|
January 30, 2015
Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells
Zuzana Saidak, Carole Le Henaff, Sofia Azzi, et al.
Journal of Biomedical Materials Research
|
March 29, 2000
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy
S A Redey, M Nardin, D Bernache-Assolant, et al.
Science (New York, N.Y.)
|
June 23, 2018
Comment on "Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death"
Abdel Aouacheria, Kyle W Cunningham, J Marie Hardwick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 1, 1993
Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect
J Bonnet, E Zerath, N Picaud, et al.
The Journal of Biological Chemistry
|
August 18, 2004
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome
Yukiho Tanimoto, Masahiko Yokozeki, Kenji Hiura, et al.
Molecular Pharmacology
|
October 1, 1994
Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor
S Nouet, P Dodey, P Renaut, et al.
Human Molecular Genetics
|
September 1, 1995
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene
A Shenker, P Chanson, L S Weinstein, et al.
Page
of 51
Search research articles
Search
Showing results (401-410 of 507) with videos related to
Sort By:
Page
of 51
The Biochemical Journal
|
January 1, 1993
Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains
F Desarnaud, J Marie, C Lombard, et al.
The American Journal of Pathology
|
February 18, 2014
Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis
Carole Le Henaff, Eric Haÿ, Frédéric Velard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 4, 2017
Anti-tumour necrosis factor α-induced lupus erythematosus panniculitis
A-L Durand, J-F Goussot, D Thiolat, et al.
The Journal of Biological Chemistry
|
January 30, 2015
Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells
Zuzana Saidak, Carole Le Henaff, Sofia Azzi, et al.
Journal of Biomedical Materials Research
|
March 29, 2000
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy
S A Redey, M Nardin, D Bernache-Assolant, et al.
Science (New York, N.Y.)
|
June 23, 2018
Comment on "Sterilizing immunity in the lung relies on targeting fungal apoptosis-like programmed cell death"
Abdel Aouacheria, Kyle W Cunningham, J Marie Hardwick, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 1, 1993
Bone morphometric changes in adjuvant-induced polyarthritic osteopenia in rats: evidence for an early bone formation defect
J Bonnet, E Zerath, N Picaud, et al.
The Journal of Biological Chemistry
|
August 18, 2004
A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome
Yukiho Tanimoto, Masahiko Yokozeki, Kenji Hiura, et al.
Molecular Pharmacology
|
October 1, 1994
Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor
S Nouet, P Dodey, P Renaut, et al.
Human Molecular Genetics
|
September 1, 1995
Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene
A Shenker, P Chanson, L S Weinstein, et al.
Page
of 51